Dr. Karlan on Current Research Evaluating PARP Inhibitor Combination Therapy in Ovarian Cancer
October 18th 2022Beth Y. Karlan, MD, discusses the current landscape of research investigating the efficacy of PARP inhibitor combination therapies for the treatment of patients with ovarian cancer.
Read More